5 Spam-Free Article(s) Found
||Teva Pharmaceutical Industries Limited
Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Jan 22, 2020 - Strapped with debt and battling legal controversies right and left, Teva’s best days could very well be behind it.
Jan 22, 2020 - Teva is set to hold the $10 support line.Company's restructuring and debt reduction on schedule.Future growth in place with two products leading it.
Jan 21, 2020 - Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.
Jan 21, 2020 - Jazz (JAZZ) receives approval for Sunosi as a treatment for excessive daytime sleepiness in narcolepsy or obstructive sleep apnea patients in Europe.